Tynept OD 37.5 is a unique formulation of Tianeptine Sodium, an atypical tricyclic antidepressant that works as a serotonin reuptake enhancer (SRE). It is primarily used to treat Major Depressive Disorder (MDD), alleviate symptoms of generalized anxiety, and improve mood stability in patients with emotional dysregulation. Tynept OD 37.5 is also useful in managing stress-induced symptoms and disorders like Borderline Personality Disorder (BPD) and Obsessive-Compulsive Disorder (OCD). The extended-release form ensures more consistent effects throughout the day.

• Sleep & Mental Health > Depression, Anxiety, BPD, OCD
  Tianeptine Sodium is a serotonin reuptake enhancer (SRE) that improves emotional stability and alleviates symptoms of Major Depressive Disorder (MDD), generalized anxiety, Borderline Personality Disorder (BPD), and Obsessive-Compulsive Disorder (OCD). Its unique mechanism of enhancing serotonin activity in the brain helps regulate mood, reduce anxiety, and stabilize emotional fluctuations.

• Sleep & Mental Health > Insomnia / Sleeping Aids
  By improving mood and reducing anxiety, Tianeptine indirectly helps improve sleep quality. It is particularly useful for patients with depression-related insomnia, as it aids in initiating sleep and enhancing sleep continuity.

• Sleep & Mental Health > Alcoholism
  Tianeptine may be used to help alleviate psychological aspects of alcohol dependence, especially by reducing stress and managing anxiety and impulse control issues associated with addiction.

Tianeptine Sodium works by enhancing serotonin reuptake, a mechanism distinct from typical antidepressants. This results in improved mood regulation and a reduction in the severity of depressive and anxiety symptoms. Its unique action allows it to be effective for a range of disorders, including Major Depressive Disorder (MDD), Borderline Personality Disorder (BPD), and Obsessive-Compulsive Disorder (OCD).

• Adult Dosage
  ⦁ Immediate-Release (IR) Tablets
  → Initial dose: 12.5 mg three times daily (before meals)
  → Maintenance dose: 800–1200 mg/day (usually around 37.5 mg/day)
  → Maximum dose: 1600 mg/day
  → Adjustments: Dosage can be gradually increased by 200 mg weekly for optimal response
  → Switching Between Forms: When switching from IR to extended-release or oral suspension, maintain the same total daily dose but adjust the frequency or divide doses as required

• Elderly
  → Reduce frequency or adjust dose as needed, starting with 12.5 mg twice daily

• Pediatric Dosage
  → Safety: Use of Tianeptine Sodium in children is not recommended due to lack of sufficient clinical trials
  → If considered, it should only be under strict medical supervision
  → No established pediatric dosing guidelines for children and adolescents

• Key Considerations
  → Not FDA-approved in many regions, including the U.S.; use cautiously under healthcare supervision
  → Risk of Abuse: Potential for misuse at higher doses, as Tianeptine can have euphoric effects
  → Side Effects: May include nausea, dizziness, headaches; serious effects like confusion and fatigue possible, especially at higher doses
  → Withdrawal Symptoms: Abrupt discontinuation may cause withdrawal similar to opioids (agitation, muscle pain)
  → Always consult a healthcare provider for individual recommendations, especially due to potential misuse and side effects

• Store in a cool, dry place.
• Keep away from direct sunlight and moisture.
• Keep in the original packaging to avoid humidity and preserve effectiveness.

• Common side effects
  → Nausea
  → Dizziness
  → Headaches
  → Gastrointestinal discomfort

• Rare but serious side effects
  → Confusion
  → Fatigue
  → Withdrawal symptoms, especially when discontinuing abruptly

• Precautions / Monitoring
  → Withdrawal may resemble opioid withdrawal (agitation, muscle pain, irritability)
  → Use only under medical supervision, especially for long-term treatment or higher doses